Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07293091 · ClinicalTrials.gov registry record · NA

Assessing the Appearance of Amino Acids in Circulation Following Consumption of Protein Beverages

A NA study of Appetite and Gastrointestinal Tolerability, sponsored by Midwest Center for Metabolic and Cardiovascular Research.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07293091: Recruiting NA study of Appetite and Gastrointestinal Tolerability, sponsored by Midwest Center for Metabolic and Cardiovascular Research.

NCT07293091 is a NA study of Appetite and Gastrointestinal Tolerability that is actively recruiting participants, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 30 participants, below the 41-participant average among 6 other Appetite trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07293091, a NA study of Appetite and Gastrointestinal Tolerability, is actively recruiting participants, sponsored by Midwest Center for Metabolic and Cardiovascular Research.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to compare the appearance of amino acids in circulation following consumption of two protein beverages in adults. Secondary objectives of this study are to assess changes in gastrointestinal tolerability, glycemia, markers of subjective and physiological appetite, and nausea.

Primary Outcome

Difference between conditions in the niAUC for the total amino acid level in plasma

Conditions Studied

Appetite Gastrointestinal Tolerability Amino Acids

Interventions

  • DIETARY_SUPPLEMENT Protein Powder
  • DIETARY_SUPPLEMENT Control Protein Powder

Study Locations (1)

Florida

  • Ocean Wellness Center - Miami Gardens

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-12-17
Est. Completion 2026-03
Phase NA
Midwest Center for Metabolic and Cardiovascular Research

26 total trials

What NCT07293091 shows while recruiting

NCT07293091 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 41-participant average among 6 other Appetite trials with a reported enrollment target (27% lower).

The record links to 3 conditions, with Appetite appearing as the primary indexed condition, and to 2 interventions - of which Protein Powder is the first listed.

NCT07293091 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07293091 about?

NCT07293091 is a clinical study titled "Assessing the Appearance of Amino Acids in Circulation Following Consumption of Protein Beverages". The objective of this study is to compare the appearance of amino acids in circulation following consumption of two protein beverages in adults. Secondary objectives of this study are to assess changes in gastrointestinal tolerability, glycemia, markers of subjective and physiological appetite, and ...

What is the current status of trial NCT07293091?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-12-17. Estimated completion is 2026-03.

What conditions does trial NCT07293091 study?

This clinical trial studies the following conditions: Appetite, Gastrointestinal Tolerability, Amino Acids.

What interventions are being tested in trial NCT07293091?

The interventions under investigation include: Protein Powder (DIETARY_SUPPLEMENT), Control Protein Powder (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07293091?

This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07293091 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Appetite

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07293091

Source: ClinicalTrials.gov NCT07293091, the US trial registry maintained by the National Library of Medicine. NCT07293091 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.